Snapshot from May 30, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Governments / Australia New Zealand Gynaecological Oncology Group
NGO

Australia New Zealand Gynaecological Oncology Group

Tracked across 1 events · 8 articles · First seen May 09, 2026 · Last active May 09, 2026

Sentiment
50
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 50
Tech
Amplia Therapeutics and ANZGOG Ovarian Cancer Study
Amplia Therapeutics and the Australia New Zealand Gynaecological Oncology Group (ANZGOG) have entered into an agreement to conduct a new clinical study, the PRROSE trial, investigating Amplia Therapeutics' lead drug narmafotinib in ovarian cancer. The…
Impact: Australia New Zealand Gynaecological Oncology Group (ANZGOG) has partnered with Amplia Therapeutics to sponsor and coordinate the PRROSE trial, leveraging its clinical trials network to address unmet medical needs in gynecological cancers.
May 09, 2026 · 8 articles
Key Actions (2)
100 Australia New Zealand Gynaecological Oncology Group entered agreement Amplia TherapeuticsAmplia Therapeutics and...
100 Amplia Therapeutics entered agreement Australia New Zealand Gynaecological Oncology GroupAmplia Therapeutics and...
NEWSDESK
Track Australia New Zealand Gynaecological Oncology Group live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.